With Concentra Biosciences expanding its stock influence in Pliant Therapeutics and Acelyrin, the two biotechs have shored up ...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech ...

Bill Anderson, the CEO of Bayer, which now owns Monsanto, the maker of glyphosate, wants the next farm bill to include ...

“Our proprietary intranasal platform has the potential to enhance drug delivery bioavailability. We believe that intranasal delivery has the potential to improve patient outcomes by providing a ...

Uncertainty around the economy, stocks and jobs are taking a toll. One economist labeled the latest reading from the ...

Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...

CBI has filed an FIR in Delhi regarding a gold-smuggling case allegedly involving actor Ranya Rao, without naming any ...

AstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

The EU is to set to release a new class of genetically modified crops from strict regulation that dates back over 20 years, ...

Today EU countries have given a mandate to start negotiations on the deregulation of new GM crops (also called NGTs). Today's meeting of EU ambassadors saw for the first time a qualified majority in ...

A Brief Overview ...